ACTRN12607000482460已完成4 期
The effect of tiotropium bromide on ventilation perfusion heterogeneity in chronic obstructive pulmonary disease
The Woolcock Institute of Medical Research0 个研究点目标入组 15 人开始时间: 2007年9月21日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 40 Years 至 -2147483648 No limit（—）
- 性别
- All
入选标准
- •Subjects must have a doctor diagnosis of COPD, greater than 15pack year smoking history and obstructed lung function that cannot be normalised with bronchodilator. Subjects must all be over the age of 50 with no history of asthma or allergic disease.
- •Minimum age: 50 years for females and 40 years for males
排除标准
- •Females under the age of 50years
研究者
相似试验
招募中
不适用
Does tiotropium bromide lead to bronchodilation in cystic fibrosis ?Human Genetics and Inherited Disorders - Cystic fibrosisCystic fibrosisACTRN12605000728639Mater Adults Hospital, South Brisbane14
已完成
4 期
Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).Pulmonary Disease, Chronic ObstructiveNCT00239408Boehringer Ingelheim311
已完成
3 期
Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPDPulmonary Disease, Chronic ObstructiveNCT00239460Boehringer Ingelheim196
招募中
3 期
The effectiveness of Tiotropium bromide in patients with severe asthmaIRCT20181015041353N1Zahedan University of Medical Sciences60
撤回
2 期
Tiotropium Handihaler vs. Tiotropium Respimat in COPDChronic Obstructive Pulmonary Disease (COPD)NCT05838703Duke University